What new medicines are poised to take the leap from breakthrough to approval in 2025? Here’s what to expect this year.

IND submission for intranasal SPC-15 treatment expected in 2025; Phase 1 clinical trial to follow upon approval SP-26 ketamine implants nearing ... This news release contains "forward-looking ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

As of September 30, 2024, cash and cash equivalents and investments were approximately $90.1 million. Shattuck believes its cash and cash equivalents and investments will be sufficient to fund its ...

Adults who were obese and exercised more than 150 min/wk at moderate intensity or higher experienced clinically important ...

Clinical, Cosmetic and International Dermatology is an international, peer-reviewed journal that focuses on the latest clinical and experimental research in all aspects of skin disease and cosmetic ..

can predict early treatment efficacy in adult Chagas patients, suggesting that MultiCruzi could serve as an endpoint in future clinical trials.

Safety concerns Keros observed in a Phase 2 trial triggered a stock selloff for what had been one of the sector’s most successful initial public offerings of the last four years, according to ...

Clinical trial design is a key aspect of the successful conduct of clinical trials. It involves deciding parameters such as the number of patients, the length of the trial, the comparator arm (in ...

Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug ...

Due to their rarity, very few patients with cytotoxic T cell lymphomas are included in clinical trials, meaning very little data exists regarding the efficacy of known T cell lymphoma therapies ...